Empirical Finance, LLC Pfizer Inc Transaction History

Empirical Finance, LLC

  • $1.7 Billion
  • Q3 2024

A detailed history of Empirical Finance, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Empirical Finance, LLC holds 195,950 shares of PFE stock, worth $5.24 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
195,950
Previous 191,710 2.21%
Holding current value
$5.24 Million
Previous $5.36 Million 5.7%
% of portfolio
0.33%
Previous 0.34%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
BUY
$27.7 - $31.39 $117,448 - $133,093
4,240 Added 2.21%
195,950 $5.67 Million
Q2 2024

Jul 30, 2024
SELL
$25.26 - $29.6 $623,694 - $730,853
-24,691 Reduced 11.41%
191,710 $5.36 Million
Q1 2024

May 06, 2024
BUY
$25.89 - $29.73 $222,731 - $255,767
8,603 Added 4.14%
216,401 $6.01 Million
Q3 2023

Nov 02, 2023
BUY
$32.09 - $37.51 $661,439 - $773,156
20,612 Added 11.01%
207,798 $6.89 Million
Q2 2023

Jul 27, 2023
BUY
$36.12 - $41.79 $1.11 Million - $1.28 Million
30,633 Added 19.57%
187,186 $6.87 Million
Q1 2023

Apr 05, 2023
BUY
$39.39 - $51.28 $354,470 - $461,468
8,999 Added 6.1%
156,553 $6.39 Million
Q4 2022

Jan 24, 2023
BUY
$41.75 - $54.5 $478,622 - $624,788
11,464 Added 8.42%
147,554 $7.56 Million
Q3 2022

Nov 04, 2022
BUY
$43.76 - $53.42 $984,206 - $1.2 Million
22,491 Added 19.8%
136,090 $5.96 Million
Q2 2022

Aug 01, 2022
BUY
$46.53 - $55.17 $281,878 - $334,219
6,058 Added 5.63%
113,599 $5.96 Million
Q1 2022

Apr 21, 2022
BUY
$45.75 - $56.69 $527,040 - $653,068
11,520 Added 12.0%
107,541 $5.57 Million
Q4 2021

Feb 04, 2022
BUY
$41.32 - $61.25 $1.05 Million - $1.56 Million
25,430 Added 36.02%
96,021 $5.67 Million
Q3 2021

Nov 12, 2021
BUY
$39.25 - $50.42 $153,860 - $197,646
3,920 Added 5.88%
70,591 $3.04 Million
Q2 2021

Aug 10, 2021
BUY
$35.91 - $40.68 $334,645 - $379,096
9,319 Added 16.25%
66,671 $2.61 Million
Q4 2020

Feb 02, 2021
BUY
$33.47 - $42.56 $328,407 - $417,598
9,812 Added 20.64%
57,352 $2.11 Million
Q3 2020

Oct 28, 2020
BUY
$31.75 - $37.25 $1.06 Million - $1.24 Million
33,397 Added 236.14%
47,540 $1.75 Million
Q3 2020

Oct 26, 2020
SELL
$31.75 - $37.25 $738,981 - $866,993
-23,275 Reduced 62.2%
14,143 $508,000
Q2 2020

Jul 20, 2020
BUY
$30.12 - $36.54 $149,063 - $180,836
4,949 Added 15.24%
37,418 $1.22 Million
Q2 2020

Jul 20, 2020
SELL
$30.12 - $36.54 $8,493 - $10,304
-282 Reduced 0.86%
32,469 $1.22 Million
Q1 2020

Apr 16, 2020
BUY
$27.03 - $38.62 $297,816 - $425,515
11,018 Added 50.7%
32,751 $1.07 Million
Q4 2019

Jan 27, 2020
BUY
$32.92 - $37.36 $249,862 - $283,562
7,590 Added 53.67%
21,733 $852,000
Q3 2019

Oct 30, 2019
BUY
$32.49 - $42.13 $7,732 - $10,026
238 Added 1.71%
14,143 $508,000
Q2 2019

Jul 09, 2019
BUY
$36.98 - $41.52 $3,069 - $3,446
83 Added 0.6%
13,905 $602,000
Q1 2019

May 10, 2019
BUY
$37.5 - $41.2 $120,637 - $132,540
3,217 Added 30.33%
13,822 $587,000
Q4 2018

Jan 22, 2019
SELL
$38.47 - $43.86 $37,739 - $43,026
-981 Reduced 8.47%
10,605 $463,000
Q3 2018

Oct 18, 2018
BUY
$34.47 - $41.81 $43,776 - $53,098
1,270 Added 12.31%
11,586 $511,000
Q2 2018

Jul 09, 2018
SELL
$32.98 - $35.16 $115,627 - $123,270
-3,506 Reduced 25.37%
10,316 $374,000
Q1 2018

May 10, 2019
BUY
$31.91 - $37.02 $211,722 - $245,627
6,635 Added 92.32%
13,822 $587,000
Q1 2018

Apr 25, 2018
BUY
$31.91 - $37.02 $229,337 - $266,062
7,187 New
7,187 $255,000
Q4 2017

Feb 01, 2018
SELL
$33.26 - $35.29 $212,531 - $225,503
-6,390 Closed
0 $0
Q2 2017

Aug 10, 2017
BUY
N/A
6,390
6,390 $215,000

Others Institutions Holding PFE

# of Institutions
3,260
Shares Held
3.61B
Call Options Held
77.2M
Put Options Held
122M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Empirical Finance, LLC Portfolio

Follow Empirical Finance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email